相关实验视频
Updated: Jun 15, 2025

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
3.7K
APE1:神经退行性疾病的一个关键焦点
Qianxiong He1, Yi Wang2, Feng Zhao3
1Department of Ophthalmology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|August 27, 2024
概括
阿普里尼克/阿普里米尼克内核酶1 (APE1) 与神经退行性疾病,如阿尔茨海默氏症和帕金森症有关. 本综述探讨了APE1的作用,寻找这些疾病的生物标志物和治疗点.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 人口老龄化增加神经退行性疾病的患病率.
- 神经退行性疾病涉及逐渐的中枢神经系统损伤.
- 阿普里尼克/阿普里米尼克内核酶1 (APE1) 与中枢神经系统疾病有关.
研究的目的:
- 审查目前对APE1参与神经退行性疾病的理解.
- 确定APE1作为潜在的生物标志物和治疗点.
- 为了澄清APE1失调的保护性或有害作用.
主要方法:
- 对APE1和神经退行症研究的文献综述.
- 在各种神经疾病中分析APE1表达.
- 对APE1在中枢神经系统中的功能进行当前研究的综合.
主要成果:
- 在阿尔茨海默病,中风,ALS,帕金森病,亨廷顿病和中观察到异常的APE1表达.
- APE1在这些疾病中的特定作用 (保护性或有害性) 尚未完全理解.
- APE1是多种神经退行性疾病病理学的重要因素.
结论:
- APE1是神经退行性疾病进展的关键参与者.
- 需要进一步的研究来阐明APE1的确切功能和治疗潜力.
- 针对APE1可能为神经退行性疾病提供新的治疗策略.
相关概念视频
Alzheimer's Disease: Overview
456
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
456
Parkinson's Disease: Overview
500
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
500
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K

